SUBSCRIBE
SUBSCRIBE

Biologics

Generative AI image of hooked syringe
Insights
Biologics push CMOs/CDMOs to expand sterile fill-finish and prefilled syringe capacity
As biologics, biosimilars and GLP-1s drive demand for sterile drug products, CMOs and CDMOs are investing in fill-finish, lyophilization, inspection and packaging capacity to keep pace with a dynamic injectable market.
August 3, 2026
 · 
2 min read
 · 
Jennifer C. Smith-Parker